68E-27905-01191
3 vaccinations
8 coded responses
15 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 782 / TX
- Registered
- 2022-02-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2022-02-23
Registered in v-safe
-
2022-02-23
Dose 3 — Pfizer-BioNTech
- 2022-02-23
-
2022-02-24
Survey response — days 1–6 daily, dose 3MedDRA: Migraine — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Survey response — days 1–6 daily, dose 3MedDRA: Breast tenderness, Tenderness — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, NauseaFree text: Tenderness in axilla, breast and armMedDRA releases: 2024-11 · check-in free text available
-
2022-02-26
Survey response — days 1–6 daily, dose 3MedDRA: Breast tenderness, Tenderness — Feeling: Good · Site: Pain · HeadacheFree text: Tenderness in axilla breast and armMedDRA releases: 2024-11 · check-in free text available
-
2022-02-27
Survey response — days 1–6 daily, dose 3MedDRA: Flank pain — Feeling: Fair · DiarrheaFree text: Flank painMedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Survey response — days 1–6 daily, dose 3MedDRA: Noninfective gingivitis — Feeling: GoodFree text: Inflammation of gumsMedDRA releases: 2024-11 · check-in free text available
- 2022-03-01
- 2022-03-02
- 2022-03-09
-
2022-03-16
Survey response — day 21, dose 3MedDRA: Nasal congestion, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Congestion, runny&stuff noseMedDRA releases: 2024-11 · check-in free text available
-
2022-03-25
Survey response — day 28, dose 3MedDRA: Sinus congestion, Sinus headache — Feeling: GoodFree text: Sinus congestion/headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-03-31
-
2022-04-06
Survey response — day 42, dose 3MedDRA: Mental impairment — Feeling: GoodFree text: Trouble thinkingMedDRA releases: 2024-11 · check-in free text available
- 2022-05-25
- 2022-08-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | No |
| 2 | 2021-04-06 | Pfizer-BioNTech | No |
| 3 | 2022-02-23 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Migraine
Systemic reaction (other): Tenderness in axilla, breast and arm
Systemic reaction (other): Tenderness in axilla breast and arm
Systemic reaction (other): Flank pain
Systemic reaction (other): Inflammation of gums
Release 11 — day 21, dose 3
Symptoms: Congestion, runny&stuff nose
Release 11 — day 28, dose 3
Symptoms: Sinus congestion/headache
Release 11 — day 42, dose 3
Symptoms: Trouble thinking
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Mental impairment | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sinus headache | · | · | ✓ |
| SRO | Breast tenderness | · | · | ✓ |
| SRO | Flank pain | · | · | ✓ |
| SRO | Migraine | · | · | ✓ |
| SRO | Noninfective gingivitis | · | · | ✓ |
| SRO | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release